Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06266650 · ClinicalTrials.gov registry record · NA
Unilateral vs Bilateral Application of Muscle Energy Techniques in Pelvic Somatic Dysfunction
A NA study of Pelvic Somatic Dysfunction, sponsored by The Touro College and University System.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06266650: Active NA study of Pelvic Somatic Dysfunction, sponsored by The Touro College and University System.
NCT06266650 is a NA study of Pelvic Somatic Dysfunction that is active but no longer recruiting, run by The Touro College and University System. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06266650, a NA study of Pelvic Somatic Dysfunction, is active but no longer recruiting, sponsored by The Touro College and University System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy of pelvic muscle energy technique online against the traditional full length osteopathic pelvic treatment protocol. The main question it aims to answer are • Can one single pelvic muscle energy technique can correct all pelvic somatic dysfunctions (SD)? Participants will * be positioned by the physician into the area of treatment into a position of resistance, which is the restrictive barrier. * be instructed to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. * be instructed to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. * These steps are repeated three to five times and then the dysfunction is reevaluated. Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one and be compared with the pelvic muscle energy group.
Primary Outcome
Restoration of anatomical landmarks symmetry Tested using forward flexion test - Standing upright subject bends forward and motion in sacroiliac joint is evaluated. The side where the investigator's thumb moves farthest is the restricted side. This side will be treated with muscle energry. Resolution will show symmetry between the sacroiliac joints.
Conditions Studied
Interventions
- OTHER Osteopathic Treatment Technique- Muscle Energy Treatment
Study Locations (1)
New York
- Touro College of Osteopathic Medicine - Harlem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-30 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT06266650 still lists
NCT06266650 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Pelvic Somatic Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Osteopathic Treatment Technique- Muscle Energy Treatment is the first listed.
NCT06266650 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06266650 about?
NCT06266650 is a clinical study titled "Unilateral vs Bilateral Application of Muscle Energy Techniques in Pelvic Somatic Dysfunction". The goal of this clinical trial is to compare the efficacy of pelvic muscle energy technique online against the traditional full length osteopathic pelvic treatment protocol. The main question it aims to answer are • Can one single pelvic muscle energy technique can correct all pelvic somatic dysfu...
What is the current status of trial NCT06266650?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-30. Estimated completion is 2025-09-30.
What conditions does trial NCT06266650 study?
This clinical trial studies the following conditions: Pelvic Somatic Dysfunction.
What interventions are being tested in trial NCT06266650?
The interventions under investigation include: Osteopathic Treatment Technique- Muscle Energy Treatment (OTHER).
Who is sponsoring clinical trial NCT06266650?
This trial is sponsored by The Touro College and University System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06266650 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06266650's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI